AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma.

Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of ...

A team of biochemists at the University of California, Santa Cruz, has developed a faster way to identify molecules in the ...

New treatments based on biological molecules like RNA give scientists unprecedented control over how cells function. But ...

You will be redirected to our submission process. Academia and both large and small industry come together at the Drug R&D II ...

The global Process Analytical Technology (PAT) market is experiencing rapid expansion, driven by the pharmaceutical ...

A team of researchers at VCU Massey Comprehensive Cancer Center discovered an innovative way to use a drug already approved ...

Automation and AI are revolutionizing the pharmaceutical industry, optimizing technical development and enabling faster, more ...

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing global research sites including Cambridge, Massachusetts, and Basel, Switzerland ...

AI promised to speed up drug discovery, but the real bottleneck is in clinical trials. This startup is using AI to accelerate ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Present day synthesis produces unimaginable levels of organic solvent waste; chemo- and biocatalysis in water are solutions to this problem. Learn how to utilize combinations of chemo- and ...